MRNA Wins FDA Panel Backing
Moderna's mRNA flu vaccine benefits outweigh the risks in adults aged 65 and above
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.